These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19671159)

  • 1. Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
    Pickard MR; Green AR; Ellis IO; Caldas C; Hedge VL; Mourtada-Maarabouni M; Williams GT
    Breast Cancer Res; 2009; 11(4):R60. PubMed ID: 19671159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate tumour suppressor Fau regulates apoptosis in human cells: an essential role for Bcl-G.
    Pickard MR; Mourtada-Maarabouni M; Williams GT
    Biochim Biophys Acta; 2011 Sep; 1812(9):1146-53. PubMed ID: 21550398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis regulators Fau and Bcl-G are down-regulated in prostate cancer.
    Pickard MR; Edwards SE; Cooper CS; Williams GT
    Prostate; 2010 Oct; 70(14):1513-23. PubMed ID: 20687224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
    Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
    Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAU regulates carboplatin resistance in ovarian cancer.
    Moss EL; Mourtada-Maarabouni M; Pickard MR; Redman CW; Williams GT
    Genes Chromosomes Cancer; 2010 Jan; 49(1):70-7. PubMed ID: 19830698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoptosis by fau revealed by functional expression cloning and antisense expression.
    Mourtada-Maarabouni M; Kirkham L; Farzaneh F; Williams GT
    Oncogene; 2004 Dec; 23(58):9419-26. PubMed ID: 15543234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
    Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J
    Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
    van Roosmalen W; Le Dévédec SE; Golani O; Smid M; Pulyakhina I; Timmermans AM; Look MP; Zi D; Pont C; de Graauw M; Naffar-Abu-Amara S; Kirsanova C; Rustici G; Hoen PA; Martens JW; Foekens JA; Geiger B; van de Water B
    J Clin Invest; 2015 Apr; 125(4):1648-64. PubMed ID: 25774502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
    Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
    Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
    Ren L; Deng B; Saloura V; Park JH; Nakamura Y
    Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
    Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
    Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
    Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
    Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
    Beke L; Kig C; Linders JT; Boens S; Boeckx A; van Heerde E; Parade M; De Bondt A; Van den Wyngaert I; Bashir T; Ogata S; Meerpoel L; Van Eynde A; Johnson CN; Beullens M; Brehmer D; Bollen M
    Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26431963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.
    Ghosh-Choudhury T; Mandal CC; Woodruff K; St Clair P; Fernandes G; Choudhury GG; Ghosh-Choudhury N
    Breast Cancer Res Treat; 2009 Nov; 118(1):213-28. PubMed ID: 18953692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.
    Speers C; Zhao SG; Kothari V; Santola A; Liu M; Wilder-Romans K; Evans J; Batra N; Bartelink H; Hayes DF; Lawrence TS; Brown PH; Pierce LJ; Feng FY
    Clin Cancer Res; 2016 Dec; 22(23):5864-5875. PubMed ID: 27225691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.
    Kuner R; Fälth M; Pressinotti NC; Brase JC; Puig SB; Metzger J; Gade S; Schäfer G; Bartsch G; Steiner E; Klocker H; Sültmann H
    J Mol Med (Berl); 2013 Feb; 91(2):237-48. PubMed ID: 22945237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of hydroquinone-induced apoptosis by downregulation of Fau is mediated by NQO1.
    Siew EL; Chan KM; Williams GT; Ross D; Inayat-Hussain SH
    Free Radic Biol Med; 2012 Oct; 53(8):1616-24. PubMed ID: 22687461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.
    Merino D; Lok SW; Visvader JE; Lindeman GJ
    Oncogene; 2016 Apr; 35(15):1877-87. PubMed ID: 26257067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.